122 results
Page 4 of 7
8-K
EX-99.1
ix48oxq u0
30 Jul 20
Other Events
12:00am
8-K
EX-99.1
lik 2wfvle2spn3s
11 May 20
Recro Reports First Quarter 2020 Financial Results and Provides Update onCOVID-19 Response and Impact
7:31am
DEFA14A
9nwxi3azk37i wc
1 May 20
Additional proxy soliciting materials
4:57pm
8-K
EX-99.1
u6m44ez
4 Mar 20
Recro Reports Financial Results for the Year Ended 2019
7:00am
8-K
EX-2.1
pivknvp9
26 Nov 19
Entry into a Material Definitive Agreement
4:54pm
8-K
EX-99.2
gf4vz7ab2h
13 Nov 19
Other Events
7:16am
8-K
EX-99.1
tvoz5cz0h nu2eqq
8 Nov 19
Recro Pharma Reports Third Quarter 2019 Financial Results
7:05am
8-K
EX-99.1
ixvzri bnb6ql
5 Nov 19
Recro Pharma’s Board of Directors Approves Separation of Acute
7:07am
8-K
EX-99.1
7q0wbc p0sam4
31 Oct 19
Other Events
10:10am
8-K
EX-99.1
ilj ofti44
8 Aug 19
Recro Pharma Reports Second Quarter 2019 Financial Results
7:58am
8-K
EX-99.1
9wcx1oubuns0trms2g
10 May 19
Recro Pharma Reports First Quarter 2019 Financial Results
7:05am
8-K
EX-99.1
rt5aheut317oxocxktu
5 Apr 19
Cost Associated with Exit or Disposal Activities
4:01pm
8-K
EX-99.1
7495r8mxwc3pz gco1ca
28 Mar 19
Recro Pharma Appoints Arnaud Ajdler to Its Board of Directors
6:05am
8-K
EX-99.1
13kzhavynv0zft4fhz
22 Mar 19
Recro Pharma Receives Complete Response Letter from the FDA for Intravenous Meloxicam
4:17pm